Therapeutics for Women's Health: Technologies and Global Markets

May 2016| BIO043F| BCC Publishing
Ask a Question

Report Highlights

The global market for women’s health therapeutics will grow from nearly $33.0 billion in 2015 to nearly $40.6 billion by 2020, with a compound annual growth rate (CAGR) of 4.2% for the period of 2015-2020.

Report Includes

  • An overview of the global market for women's health therapeutics.
  • Analyses of global market trends, with data from 2014, 2015, and projections of CAGRs through 2020.
  • Information on women's health disorder types including infertility, endometriosis, postmenopausal osteoporosis, menopause, and polycystic ovary syndrome (PCOS).
  • Detailed analysis of annual costs as well discussion on branded vs. generic options.
  • Specifics on market factors such as drivers, restraints, and competition.
  • Information on marketed as well as pipeline drugs and therapies.
  • Profiles of major players in the industry.

Report Scope

This report is an analytical business tool whose primary purpose is to describe the thorough evaluation of the global market for women’s health therapeutics. The format of the study is organized around the following topics:

  • Detailed study around women’s diseases such as endometriosis, postmenopausal osteoporosis, menopause, breast cancer and polycystic ovary syndrome (PCOS).
  • Disease incidence and prevalence.
  • Regulatory structure.
  • Market characterization, unmet need, market size and segmentation.
  • Market drivers and restraints.
  • Detailed market projections through 2020.
  • Competition and market shares.
  • Pricing and reimbursement.
  • Marketed and pipeline (R&D) products along with description, regulatory status and clinical trials.
  • Observations and conclusions regarding the future of women’s health therapeutics market.
  • Profiles of market participants and associations.

Analyst Credentials

Dr. Ritu Thakur is an independent consultant based in New Delhi, India with 10+ years of experience in consulting, business/market research, business & report writing, analytics, content development & management and translation. She has prior work experience with Panasonic (Healthcare Division), GlobalData (U.K.-based market research firm) and several other development stage/early stage companies including Biovo, Diabesity, Medibrane, ScaleThings, EndoGI, Ramot Biomedical Eng and NeverWet. In her previous assignments, she has delivered hundreds of small to large scale custom projects on pharmaceutical, medical and biotechnology subjects. She has developed reports for BCC Research for more than four years and has worked as an author for healthcare and other related industries such as pharmaceuticals, biotechnology and medical devices.

Latest reports include:

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter Name Pages Price Member Price
Full Report: Therapeutics for Women's Health: Technologies and Global Markets 230 $2,750 Free
Chapter- 1: Introduction4Free
Chapter- 2: SUMMARY2$250Free
Chapter- 3: OVERVIEW OF WOMEN'S HEALTH DISORDERS10$120Free
Chapter- 4: MENOPAUSE-RELATED SYMPTOMS AND DISEASES12$143Free
Chapter- 5: POSTMENOPAUSAL OSTEOPOROSIS19$227Free
Chapter- 6: ENDOMETRIOSIS16$191Free
Chapter- 7: POLYCYSTIC OVARY SYNDROME11$132Free
Chapter- 8: BREAST CANCER20$239Free
Chapter- 9: WOMEN'S HEALTH DISORDER THERAPEUTICS MARKET ASSESSMENT19$227Free
Chapter- 10: COMPETITION AND MARKET SHARES2$24Free
Chapter- 11: MARKET STRATEGY11$132Free
Chapter- 12: DRUG PIPELINE ANALYSIS44$526Free
Chapter- 13: REGULATORY STRUCTURE5$60Free
Chapter- 14: PRICING AND REIMBURSEMENT4$48Free
Chapter- 15: CONCLUSIONS-OUTLOOK FOR WOMEN'S HEALTH THERAPEUTICS10$120Free
Chapter- 16: COMPANY PROFILES28$335Free
Chapter- 17: INDUSTRY AND PROFESSIONAL ORGANIZATIONS10$120Free
Chapter- 18: ABBREVIATIONS3$36Free
Published - May-2014| Analyst - Dr. Ritu Thakur Dangi| Code - BIO043E

Report Highlights

The global market for women’s health therapeutics was worth nearly $18.3 billion in 2012. The market is expected to increase from nearly $19 billion in 2013 to nearly $22.5 billion by 2018, a compound annual growth rate (CAGR) of 3.5% for the five-year period, 2013 to 2018.

Report Includes

  • An overview of the global therapeutics for women's health market.
  • Analyses of global market trends, with data from 2012 and 2013, and projections of CAGRs through 2018.
  • Information on women's health disorder types including infertility, endometriosis, postmenopausal osteoporosis, menopause, and polycystic ovary syndrome (PCOS).
  • Detailed analysis of annual costs as well discussion on branded vs. generics.
  • Specifics on market factors such as drivers, restraints, competition, and market shares.
  • Information on marketed as well as pipeline drugs and therapies.
Published - Mar-2009| Analyst - Melissa Elder| Code - BIO043D

Report Highlights

  • The U.S. market for therapeutics and diagnostics for women’s disorders was worth $29.9 billion in 2008. This should increase to $50.0 billion in 2013, for a compound annual growth rate (CAGR) of 10.9%.
  • The rheumatoid arthritis and osteoporosis segment has the largest share of the market, generating $10.6 billion in 2008. This is expected to grow at a CAGR of 11.5% to reach $18.2 billion in 2013.
  • Reproductive related therapies and diagnostics currently have the second largest market share, worth $5.9 billion in 2008. This should reach $7.5 billion in 2013, for a CAGR of 5.0%.
Published - May-2005| Analyst - Melissa Elder| Code - BIO043C

Report Highlights

  • The total U.S. market for new therapeutics and diagnostics for women’s disorders was estimated at more than $25 billion in 2004 and is expected to reach nearly $41 billion in 2009, rising at an AAGR (average annual growth rate) of 10.3%.
  • Treatments for cancers specific to women will rise the fastest, at an AAGR of 12.6% and will lead revenues in 2009.
  • Reproductive-related therapies and diagnostics currently represent the largest market segment, but, rising at an AGR of 8.4%, will lag slightly by 2009.
  • Treatments for gynecological diseases and infections and for rheumatoid arthritis and osteoporosis also represent large market segments.
Published - Jan-2001| Analyst - Mary Anne Crandall| Code - BIO043B

Report Highlights

  • The total current U.S. market for new therapeutics and diagnostics for women's disorders in 1999 reached $16.9 billion at the manufacturers' level. The growing numbers of women combined with the growing trend to take an active role in healthcare has driven growth in this market. By 2005, it is anticipated that revenues will likely reach $31.9 billion, growing at an average annual rate of 8.7%.
  • The reproductive-related therapeutics and diagnostics holds the largest market revenues position representing 31.9% and accounting for $5.4 billion of the total in 1999. Large numbers of women in the baby boomer age group, coupled with large numbers of the mini-boomers (daughters of the baby boomer generation), contributed to the reproductive-related therapeutics and diagnostics' dominate role in 1999. It is anticipated that the reproductive-related therapeutics and diagnostics will remain the largest market share throughout the forecast period as it crosses $10 billion by 2005.

When do I get the report?
Most reports are fulfilled immediately. In some cases, it could take up to 24 hours.

In what format does this report get delivered to me?
We will send you an email with login credentials to access the report. You will also be able to download the pdf.

What are the free reports included in my purchase?
They consist of a collection of current reports from various partner publishers scanning multiple industries.

What is the difference between BCC Research and BCC Publishing?
BCC Research curates thousands of reports from different sources and provides access to this content to our clients. BCC Publishing is the publication arm of BCC Research (one of several publishers in our portal).

What reports do I get 'discounts' on with my purchase?
All reports. BCC Publishing reports will be available for a 50% discount. All other partner publishers are also available at deeply discounted rates.

Where are you located?
Wellesley Massachusetts, just outside of Boston, Massachusetts, USA.

How long has BCC Research been around?
We are approaching our 50 year anniversary in 2021!

What if I want you to invoice me for payment via Purchase Order?
Simply choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.

What if I have a question about your reports?
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times, and included in every purchase, to help our customers find the research they need-when they need it.

Can I share this report with my team?
Absolutely yes, with the purchase of additional user licenses.

Can I use your research in my presentation?
Absolutely yes, so long as the publisher is properly cited.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report